美国生物制药公司Axsome Therapeutics, Inc.（股票代码：AXSM）今日盘前股价大涨5.80%，引发市场广泛关注。
此次股价上涨很可能与该公司即将发布的季度财报有关。根据财经数据提供商FactSet Research Systems Inc.的信息，Axsome Therapeutics计划于今日（周一）上午7:00发布2025年第二季度财报。
分析师预期Axsome Therapeutics本季度每股亏损1.06美元。尽管预期仍为亏损，但投资者似乎对公司的业绩报告持乐观态度。生物制药公司的股价常常受到财报、临床试验结果和监管决定等因素的显著影响。投资者可能正在期待公司在财报电话会议上披露的最新研发进展、市场策略或财务状况的积极信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.